定量肌肉MRI与临床结局量化CMT1A疾病进展
一项前瞻性单中心自然史研究纳入33例经基因确诊的CMT1A成人患者和33名健康对照,随访24个月,评估定量肌肉MRI与临床量表对疾病进展的敏感性。结果显示远端小腿肌肉PDFF在12个月和24个月均显著升高,MFM32和INQoL亦早期恶化,提示这些指标可作为12个月临床试验终点。
要点
- 远端小腿PDFF在12个月增加1.1%,24个月增加2.1%,可早期检测CMT1A进展。
- MFM32总分在12个月下降3.4%,24个月下降5.8%,与INQoL联合可作敏感终点。
- 基线远端小腿PDFF与年龄、病程、6MWD、10MWT、MFM32及MRC总和评分相关。
核心结论
- 基于3D全肌肉分割的远端小腿PDFF可在12个月内检测CMT1A疾病进展。
- PDFF联合MFM32和INQoL可为成人CMT1A未来临床试验提供敏感的12个月终点。
研究设计与样本
- 前瞻性、单中心自然史研究,纳入33例基因确诊的CMT1A成人患者和33名健康对照,随访24个月(基线、12、24个月)。
- 定量肌肉MRI对18块近端和10块远端小腿肌肉进行自动化3D全肌肉分割,量化PDFF(%)和T2H2O(ms)。
- 临床结局包括CMTNSv2、ONLS、MFM32、6MWD、10MWT、30秒坐立试验、9HPT、MRC总和评分及等长肌力测试;患者报告结局包括INQoL、ActivLim、疲劳严重度量表和简明疼痛量表。
主要发现
- 基线时CMT1A患者所有小腿肌肉PDFF均升高(p < 0.001)。
- 远端小腿PDFF在12个月增加1.1%(95% CI 0.7-1.4,p < 0.001),24个月增加2.1%(95% CI 1.4-2.8,p < 0.001)。
- 远端前外侧间室T2H2O在12个月增加1.2 ms(95% CI 0.3-2.1,p < 0.001),24个月增加1.5 ms(95% CI 0.4-2.6,p < 0.001)。
- 近端小腿PDFF和T2H2O基本稳定。
- MFM32总分在12个月下降3.4%(95% CI -4.1至-2.6,p < 0.001),24个月下降5.8%(95% CI -6.9至-4.7,p < 0.001);INQoL评分在12个月恶化15.1(95% CI 10.0-20.2,p < 0.001),24个月恶化23.6(95% CI 18.8-28.7,p < 0.001);9HPT在24个月恶化2.0秒(95% CI 0.5-3.4,p < 0.05);CMTNSv2在24个月恶化3.3(95% CI 2.2-4.5,p < 0.001)。
临床怎么用
- 在成人CMT1A临床试验中,可考虑将远端小腿PDFF作为12个月敏感影像学终点。
- MFM32和INQoL可作为评估疾病进展的临床和患者报告结局指标。
局限性
- 研究为单中心自然史研究,样本量有限(33例患者),结果需在更大样本中验证。
- 研究未设置干预,仅观察24个月,长期进展速率及治疗反应性尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Charcot-Marie-Tooth neuropathy type 1A (CMT1A) is a slowly progressive demyelinating neuropathy with distal muscle weakness and atrophy. Sensitive, objective outcome measures are needed for future clinical trials. We aimed to identify responsive imaging and clinical biomarkers in CMT1A over 24 months. METHODS: In this prospective, monocentric natural history study, ambulatory adults with genetically confirmed CMT1A and healthy controls were enrolled for 3 visits (baseline, 12, and 24 months). Quantitative muscle MRI quantified proton density fat fraction (PDFF, %) and disease activity with water T2 (T2H2O, ms), using automated 3D whole-muscle segmentation of 18 proximal and 10 distal leg muscles. Clinical outcomes comprised the Charcot-Marie-Tooth Neuropathy Score version 2 (CMTNSv2), Overall Neuropathy Limitations Score, 32-item Motor Function Measure (MFM32), 6-Minute Walk Distance (6MWD), 10-Meter Walk Test (10MWT), 30-Second Sit-to-Stand, 9-Hole Peg Test (9HPT), MRC sum score, and isometric strength testing. Patient-reported measures included the Individualized Neuromuscular Quality of Life (INQoL), ActivLim, Fatigue Severity Scale, and Brief Pain Inventory. RESULTS: Thirty-three patients with CMT1A (43.8 years, 64% female) and 33 controls (42.2 years, 61% female) were included. At baseline, PDFF (%) was elevated in CMT1A across all leg muscles (p < 0.001). Distal leg PDFF (%) increased at 12 months (+1.1%, 95% CI 0.7-1.4, p < 0.001) and 24 months (+2.1%, 95% CI 1.4-2.8, p < 0.001). T2H2O in the anterolateral distal compartment increased at 12 months (+1.2 ms, 95% CI 0.3-2.1, p < 0.001) and 24 months (+1.5 ms, 95% CI 0.4-2.6, p < 0.001). Proximal leg PDFF (%) and T2H2O remained largely stable. The MFM32 total score declined at 12 months (-3.4%, 95% CI -4.1 to -2.6, p < 0.001) and 24 months (-5.8%, 95% CI -6.9 to -4.7, p < 0.001). INQoL scores worsened at 12 months (+15.1, 95% CI 10.0-20.2, p < 0.001) and 24 months (+23.6, 95% CI 18.8-28.7, p < 0.001). The 9HPT (+2.0s, 95% CI 0.5-3.4, p < 0.05) and CMTNSv2 (+3.3, 95% CI 2.2-4.5, p < 0.001) worsened at 24 months. Baseline distal leg PDFF (%) correlated with age, disease duration, 6MWD, 10MWT, MFM32, and MRC sum score. DISCUSSION: Distal leg PDFF (%) from 3D whole-muscle segmentation detects CMT1A progression within 12 months. Combined with the MFM32 and INQoL, these measures enable sensitive 12-month endpoints for future clinical trials in adults with CMT1A.
引用
- Iterbeke L, Huysmans L, Bamps K, et al. Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes. Neurology. 2026. PMID: 42555899. doi:10.1212/WNL.0000000000218411
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。